Amyloidosis Research Consortium Inc.

Mission

The Amyloidosis Research Consortium (ARC) is a nonprofit organization dedicated to driving advances in the awareness, science, and treatment of amyloid diseases. ARC’s mission is to improve and extend the lives of those with amyloidosis. ARC is committed to collaborative efforts that accelerate the pace of discovery, expand patient access to the most effective care, and improve short- and long-term outcomes. Working with partners in industry, government, and academia, ARC seeks to spark innovation and to bring promising treatments from labs to clinics. ARC’s outreach and education inform and empower patients, families, caregivers, physicians, and researchers.

NEWTON MA | EIN: 47-2589708

Profile managed by nonprofit | Is this your nonprofit?

501(c)(3) organization

320 NEVADA ST STE 210,
NEWTON MA 02460-1435

https://WWW.ARCI.ORG

617-467-5170

Amyloidosis Research Consortium Inc.

Mission

NEWTON MA | EIN: 47-2589708

Profile managed by nonprofit | Is this your nonprofit?

501(c)(3) organization

320 NEVADA ST STE 210,
NEWTON MA 02460-1435

https://WWW.ARCI.ORG

617-467-5170

Beacon Report

Great
Good
Needs Improvement
Poor
Not Scored
Additional Information

Program Expense Ratio:71.44% of total expenses

SCORE100%

Average percentage of expenses on programs and services over the past three years. A ratio greater than 70.00% receives full credit.

ExpensesFY2021

Administrative: 5.4%
Fundraising: 9.6%
Program: 85.0%

ExpensesFY2022

Administrative: 12.2%
Fundraising: 18.8%
Program: 69.0%

ExpensesFY2023

Administrative: 14.1%
Fundraising: 21.7%
Program: 64.1%

Administrative
Fundraising
Program

Source: Public data from IRS Form 990

Liabilities to Assets Ratio:7.61% of total assets

SCORE100%

Working Capital:1.32 years of reserves

SCORE100%

Fundraising Efficiency:$0.17 to raise a dollar

SCORE100%

Evaluation area metrics
Score	Metric
100%	Program Expense Ratio:71.44% of total expenses Average percentage of expenses on programs and services over the past three years. A ratio greater than 70.00% receives full credit. ExpensesFY2021 Administrative: 5.4% Fundraising: 9.6% Program: 85.0% ExpensesFY2022 Administrative: 12.2% Fundraising: 18.8% Program: 69.0% ExpensesFY2023 Administrative: 14.1% Fundraising: 21.7% Program: 64.1% Administrative Fundraising Program Source: Public data from IRS Form 990
100%	Liabilities to Assets Ratio:7.61% of total assets
100%	Working Capital:1.32 years of reserves
100%	Fundraising Efficiency:$0.17 to raise a dollar

Science behind the numbers

Amyloidosis Research Consortium Inc.

Mission

Vision

Goals

Amyloidosis Research Consortium Inc.

Mission

Vision

Goals

Beacon Report

Error attempting donation

You're too fast!

Mission

Mission

Beacon Report